-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QqsTkjtgHJeMSe3GyTMNG/5WIhU3ZTSIiKJtIUdnD9WdcBiscmkJ5jy9ECe2pVRt Frx2aFnE36xnN3HqgAnkPw== 0001209191-08-018679.txt : 20080317 0001209191-08-018679.hdr.sgml : 20080317 20080317182620 ACCESSION NUMBER: 0001209191-08-018679 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080313 FILED AS OF DATE: 20080317 DATE AS OF CHANGE: 20080317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVANIR PHARMACEUTICALS CENTRAL INDEX KEY: 0000858803 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330314804 STATE OF INCORPORATION: CA FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 101 ENTERPRISE STREET 2: SUITE 300 CITY: ALISO VIEJO STATE: CA ZIP: 92656 BUSINESS PHONE: 949-389-6700 MAIL ADDRESS: STREET 1: 101 ENTERPRISE STREET 2: SUITE 300 CITY: ALISO VIEJO STATE: CA ZIP: 92656 FORMER COMPANY: FORMER CONFORMED NAME: LIDAK PHARMACEUTICALS DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Katkin Keith CENTRAL INDEX KEY: 0001314596 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15803 FILM NUMBER: 08694448 BUSINESS ADDRESS: BUSINESS PHONE: (510) 747-3900 MAIL ADDRESS: STREET 1: C/O PENINSULA PHARMACEUTICALS, INC. STREET 2: 1751 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2008-03-13 0 0000858803 AVANIR PHARMACEUTICALS AVNR 0001314596 Katkin Keith 101 ENTERPRISE, SUITE 300 ALISO VIEJO CA 92656 1 1 0 0 President and CEO Class A Common Stock 2008-03-13 4 F 0 1539 1.10 D 579729 D Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due upon the vesting of restricted stock award granted to the Reporting Person under the Issuer's 2005 Equity Incentive Plan. The shares surrendered were valued based on the closing price of the Issuer's Class A common stock on the vesting date. Includes shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions. /s/ Christine Ocampo, by power of attorney 2008-03-17 EX-24.4_231802 2 attachment1.htm EX-24 DOCUMENT 
POWER OF ATTORNEY

The undersigned hereby constitutes and appoints each of Christine Ocampo and
Ryan Murr, the
undersigned's true and lawful attorneys-in-fact to:

(1)	execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or
	director Avanir Pharmaceuticals (the "Company"), Forms 3, 4 and 5 in accordance
with
	Section 16(a) of the Securities Exchange Act of 1934 (the "Exchange Act"), and
the rules
	thereunder;

(2)	do and perform any and all acts for and on behalf of the undersigned which
may be necessary or
	desirable to complete and execute any such Form 3, 4 or 5, complete and execute
any amendment
	or amendments thereto, and timely file any such form with the United States
Securities and
	Exchange Commission and any stock exchange or similar authority; and

(3)	take any other action of any type whatsoever in connection with the
foregoing which, in the
	opinion of such attorney-in-fact, may be of benefit to, in the best interest
of, or legally required
	by, the undersigned, it being understood that the documents executed by such
attorney-in-fact on
	behalf of the undersigned pursuant to this Power of Attorney shall be in such
form and shall
	contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's
	discretion.

      The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and
perform any and every act and thing whatsoever requisite, necessary or proper to
be done in the exercise
of any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned
might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact's substitute
or substitutes, shall lawfully
do or cause to be done pursuant to this power of attorney.  The undersigned
acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not
assuming, nor is the Company assuming, any of the undersigned's responsibilities
to comply with
Section 16 of the Exchange Act.

      This Power of Attorney shall remain in full force and effect until the
undersigned is no longer
required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of
and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered
to the attorneys-in-fact.

The undersigned has caused this Power of Attorney to be executed as of this 10th
day
of March, 2008.


/s/ Keith A. Katkin
Signature

Keith A. Katkin
Print Name
-----END PRIVACY-ENHANCED MESSAGE-----